Cells expressing AD-related genotypes have also shown an upregulation in C-end terminal fragments (a byproduct of APP after beta-secretase processing) [49], beta-secretase in released EVs, and co-localization of beta-secretase enzyme 1 with early EV markers [13]. The gene discussed is APP; the disease is Alzheimer disease.